25th September 2020 Content supplied by: Thermo Fisher Scientific (Clinical Applications)
Flu Testing During COVID-19
Flu season 2020/2021 will be unlike any other, with COVID-19 infections expected to remain at high levels a key part of patient management this winter will be to quickly and accurately determine whether presenting symptomatic patients have flu or COVID-19.
The Thermo Scientific™ Xpect™ Flu A&B is a rapid, lateral flow immunoassay for the direct qualitative detection of Influenza A and Influenza B viral antigens, that allows physicians to make a fast diagnosis with confidence, which is essential for reducing secondary testing, decreasing unnecessary antibiotic use, and guiding appropriate antiviral therapy.
Features and Benefits of the Xpect™ Flu A&B test include:
- Accurate, easy-to-read visual results in just 15 minutes
- 100% specificity (from product insert)
- A simple, walk-away procedure with less than one minute hands-on time
Date Published: 25th September 2020
Source article link: View